Home›Companies›Biotech & Pharma›Primary Bioscience

Primary Bioscience, Inc.

Developing a protein sequencing device for screening multiple biological markers.

Updated Nov 10, 2026·Latest SEC filing Jun 23, 2026·Suggest an edit

About Primary Bioscience

Primary Bioscience is a private company based in Seattle, Washington, incorporated in 2023 in Washington. It has reported $1,300,000 raised in one offering on Form D since October 2025. Its chief executive is Stacy Anderson.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 2, 2025Oct 7, 2025amended Jun 23, 2026$1,300,000of $1.8M target3$433KEquity, Options, Securities on exerciseRule 506(b)Form D/A ↗2 earlier filings

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Primary Bioscience's Form D filed Jun 23, 2026.

SA

Sources

  1. SECPrimary Bioscience, Inc. Form D/A, filed Oct 24, 2025
  2. SECPrimary Bioscience, Inc. Form D, filed Oct 7, 2025
  3. SECPrimary Bioscience, Inc. filing history
  4. ResearchUniversity of Washington CoMotion: Primary Bioscience